An assistant professor at the Medical University of South Carolina is one of three men arrested in the last week for their alleged roles in a scheme to “manufacture, distribute, and sell to the public stem cells and stem-cell procedures that were not approved by the Food and Drug Administration,” according to a news release issued on Wednesday by the Federal Bureau of Investigation.
The South Carolina researcher, Vincent Dammai, is alleged to have used university facilities to create stem cells from umbilical-cord blood that one of the other defendants, a midwife, obtained from birth mothers. The stem cells were then sold to people with cancer and other incurable diseases under the illusion that the cells were part of an FDA-approved treatment. The scheme netted $1.5-million for the defendants, the FBI said.
The university released a statement saying that Professor Dammai had been placed on administrative leave and that it was cooperating in the investigation. Nature reported that he could not be reached for comment.

